Advanced soft-tissue sarcomas are still incurable in the vast majority of p
atients. The currently available standard methods of treatment such as surg
ery, radiation therapy, and chemotherapy have a very modest impact on the n
atural history of advanced soft tissue sarcomas. Nevertheless, until new st
rategies become widely available and applicable to this disease, we are obl
igated to optimize the current resources and make the best use of these mod
alities. We discuss the approaches of standard chemotherapy used in a dose-
intensive fashion (especially in high-risk patients at an earlier stage), a
ttempts to find new drugs with activity in this disease, and tests of the c
oncepts of anti-angiogenic and differentiation therapy. To improve cure rat
es, patients and physicians must be encouraged to participate in multidisci
plinary clinical trials. Semin. Surg. Oncol. 27:47-51, 1999. (C) 1999 Wiley
-Liss, Inc.